Over 300 Colorado Auctions End Tomorrow 05/12 - Bid Now
Over 150 Total Lots Up For Auction at Two Locations - PA 05/15, NY 05/20

Accuray fiscal second quarter revenue exceeds $100 million and increases 15 percent year-over-year; gross orders of $77.9 millio

Press releases may be edited for formatting or style | January 25, 2018 Business Affairs
SUNNYVALE, Calif., Jan. 23, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second fiscal quarter ended December 31, 2017.

Fiscal Second Quarter Highlights

Revenue increased 15 percent year-over-year to $100.3 million driven by product revenue growth of 33 percent
stats Advertisement
DOTmed text ad

Training and education based on your needs

Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money

stats

Gross orders were $77.9 million; net orders were $52.6 million. Ending backlog increased 10 percent year-over-year to $470.5 million
Gross margin expanded approximately 340 basis points year-over-year to 39.2 percent driven by improvements in product gross margins
Entered a $40 million term loan to facilitate retirement of the remaining February 2018 convertible debt, which could reduce potential share dilution to the extent settled with cash
"We have made solid progress towards achieving consistent operating performance during the first half of the fiscal year and we believe we are well on track to achieve our fiscal 2018 guidance, which was originally provided in August," said Joshua H. Levine, president and chief executive officer. "Our 33 percent year-over-year product revenue growth during the second quarter was primarily driven by solid implementation of our strategies to improve distributor order to revenue conversion and increased Radixact contribution. As the fiscal year progresses, we believe that we will see the initial signs of commercial momentum in the U.S., which could enable us to expand our growth rate in fiscal 2019. We are building this momentum through the market's increased recognition of the clinical benefits of our radiation therapy solutions."

Fiscal Second Quarter Results

Total revenue was $100.3 million compared to $87.5 million in the prior fiscal year second quarter. Product revenue totaled $47.1 million compared to $35.4 million in the prior fiscal year second quarter, while service revenue totaled $53.2 million compared to $52.1 million in the prior fiscal year second quarter. The increase in product revenue was primarily due to improved backlog conversion of orders to revenue from the EIMEA and APAC regions.

Total gross profit for the 2018 fiscal second quarter was $39.4 million or 39.2 percent of sales, comprised of product gross margin of 43.0 percent and service gross margin of 35.9 percent. This compares to total gross profit of $31.4 million or 35.9 percent of sales, comprised of product gross margin of 35.1 percent and service gross margin of 36.4 percent for the prior fiscal year second quarter. The increase in product gross margin was due to product volume and mix, as well as intangible amortization expiring in the fourth quarter of the prior fiscal year.

You Must Be Logged In To Post A Comment